Crescita Therapeutics Inc. is a publicly traded Canadian commercial dermatology company focused on developing and commercializing innovative, differentiated topical products for treating medical conditions in dermatology and pain. Their expertise lies in transdermal drug delivery, and they own and operate a manufacturing facility in Laval, Québec. Crescita markets its products in Canada, the U.S., and internationally, with a portfolio of products licensed to partners in approximately 40 countries.
Corporate head office, overseeing commercial operations, business development, research and development coordination, and administrative functions.
Modern office facilities located in a commercial business park, designed to support administrative and strategic operations.
A collaborative and innovative environment typical of a growth-oriented pharmaceutical company, focused on scientific advancement and patient outcomes.
Strategically located in the Greater Toronto Area, providing access to a skilled talent pool, research institutions, and a vibrant life sciences ecosystem.
Crescita Therapeutics supports global commercialization of its dermatology and pain products through a network of licensing and distribution partners. Its products are marketed or approved in Canada, the U.S., and approximately 40 other countries across Europe, Asia, the Middle East, and Latin America. The company's global functions include business development, alliance management with international partners, and ensuring manufacturing supply for worldwide distribution.
2800 Matheson Blvd. East, Suite 220
Mississauga
Ontario
Canada
Address: Laval, Quebec, Canada (Specific street address of manufacturing plant not broadly publicized)
Serves as the primary manufacturing and production hub, ensuring quality control and supply chain management for its proprietary and partnered products.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Crescita Therapeutics' leadership includes:
Crescita Therapeutics has been backed by several prominent investors over the years, including:
In the past 12 months, Crescita Therapeutics saw a key change in its executive team with the appointment of a new Chief Financial Officer.
Discover the tools Crescita Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Crescita Therapeutics commonly uses the first initial followed by the last name for their email addresses. Other formats might exist but this is a widely observed pattern for companies of similar structure.
[first_initial][last]@crescitatherapeutics.com
Format
jdoe@crescitatherapeutics.com
Example
90%
Success rate
Cision (PRNewswire) • April 30, 2024
Crescita Therapeutics Inc. announced that it has granted an aggregate of 320,000 stock options to certain directors, officers and employees of the Company....more
Cision (PRNewswire) • March 7, 2024
Crescita Therapeutics Inc. announced its financial results for the fourth quarter and fiscal year ended December 31, 2023. The company highlighted revenue growth and progress in its commercial and pipeline products....more
Cision (PRNewswire) • February 13, 2024
Crescita Therapeutics Inc. announced that its commercial partner, Cantabria Labs, S.A., received marketing authorization for Pliaglis® Cream in Kuwait and Qatar, expanding its presence in the Middle East North Africa (MENA) region....more
Cision (PRNewswire) • October 2, 2023
Crescita Therapeutics Inc. announced the appointment of Ms. Linda K. Angove, CPA, CA, as Chief Financial Officer of the Company, effective October 2, 2023....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Crescita Therapeutics, are just a search away.